Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, open-label study in stable patients switched from typical and atypical oral antipsychotics

被引：0
|
作者：
Cetin, M [1 ]
Ebrinc, S [1 ]
Basoglu, C [1 ]
Semiz, UB [1 ]
Gunay, H [1 ]
Iyisoy, MS [1 ]
Ergun, BM [1 ]
Gunes, C [1 ]
Sahan, A [1 ]
Oguz, M [1 ]
Noyan, O [1 ]
机构：
[1] Gulhane Haydarpasa Training Hosp, Dept Psychiat, Istanbul, Turkey
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2005年 / 15卷
关键词：
D O I：
10.1016/S0924-977X(05)80287-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S134 / S135
页数：2
相关论文
共 50 条
  • [1] Safety and efficacy of long-acting risperidone in schizophrenia: A 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics
    Lindenmayer, JP
    Eerdekens, E
    Berry, SA
    Eerdekens, M
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (08) : 1084 - 1089
  • [2] Safety and efficacy of long-acting risperidone in schizophrenia: A 12-week open-label study in stable patients switched from oral antipsychotic treatment
    Lindenmayer, J
    Eerdekens, E
    Berry, S
    Eerdekens, M
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 173 - 173
  • [3] Effectiveness and tolerability of long-acting risperidone: A 9-month open-label extension of a 12-week switching study from oral antipsychotics
    Kim, Chang Yoon
    Chung, Seockhoon
    Hahm, Bong-Jin
    Hong, Kyung Sue
    Yoon, Jin-Sang
    Kim, Young-Hoon
    Bahk, Won-Myong
    Lee, Sang-Yeol
    Lee, Yanghyun
    Chung, In-Won
    Kim, Chan-Hyung
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 (03) : 192 - 198
  • [4] Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics
    Turner, M
    Eerdekens, E
    Jacko, M
    Eerdekens, M
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (04) : 241 - 249
  • [5] Long-acting injectable risperidone safety and efficacy in patients switched from conventional depot antipsychotics
    Turner, M
    Eerdekens, M
    Jacko, M
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 305 - 305
  • [6] Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety
    Hawley, Chris
    Turner, Martin
    Latif, Muhammud A.
    Curtis, Vivienne
    Saleem, Packeruther T.
    Wilton, Kristina
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (01) : 37 - 46
  • [7] A study of the efficacy and safety of switching from oral risperidone to risperidone long-acting injection in older patients with schizophrenia
    Suzuki, Hidenobu
    Inoue, Yuichi
    Gen, Keishi
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2012, 2 (06) : 227 - 234
  • [8] Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study
    Iyo, Masaomi
    Ishigooka, Jun
    Nakamura, Masatoshi
    Sakaguchi, Reiko
    Okamoto, Keisuke
    Mao, Yongcai
    Tsai, Joyce
    Fitzgerald, Alison
    Takai, Kentaro
    Higuchi, Teruhiko
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 2683 - 2695
  • [9] A comparative efficacy and safety study of long-acting risperidone injection and risperidone oral tablets among hospitalized patients: 12-week randomized, single-blind study
    Bai, Y. M.
    Chen, T. T.
    Wu, B.
    Hung, C. H.
    Lin, W. K.
    Hu, T. M.
    Lin, C. -Y.
    Chou, P.
    PHARMACOPSYCHIATRY, 2006, 39 (04) : 135 - 141
  • [10] Safety and efficacy of long-acting injectable risperidone in daily practice: an open-label, noninterventional, prospective study in schizophrenia and related disorders
    Parellada, Eduard
    Kouniakis, Filippos
    Siurkute, Aldona
    Schreiner, Andreas
    Don, Liana
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2010, 25 (03) : 149 - 154
12345